|
CPS Lunch and Learn Webinar Series (non CE accredited): Elinzanentant (Lynkuet): A Neurokinin 1 (NK1) and Neurokinin 3 (NK3) Receptor Antagonist Indicated for the Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause | Sept. 24, 2026 | 12PM
Thursday, September 24, 2026, 12:00 AM - 1:00 PM MDT
Category: Webinar
CPS Lunch and Learn Webinar Series (non CE accredited): Elinzanentant (Lynkuet): A Neurokinin 1 (NK1) and Neurokinin 3 (NK3) Receptor Antagonist Indicated for the Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause | Sept. 24, 2026 | 12PM -1PM Barbara Yaeger, PhD; Lead Medical Science Liaison, Bayer Women’s HealthcareThursday September 24, 202612:00 PM - 1:00 PM MDT
Register Here: https://copharm.memberclicks.net/bayer
|